82 FR 8619 - National Cancer Institute; Notice of Closed Meetings
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 82, Issue 17 (January 27, 2017)
National Institutes of Health
Federal Register Volume 82, Issue 17 (January 27, 2017)
| Page Range | 8619-8620 | |
| FR Document | 2017-01867 |
[Federal Register Volume 82, Number 17 (Friday, January 27, 2017)] [Notices] [Pages 8619-8620] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-01867] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications/contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications/contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel; Revision Applications for Biological Comparisons in Patient- Derived Models of Cancer (U01). Date: February 24, 2017. Time: 10:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W032, Rockville, MD 20850, (Telephone Conference Call). Contact Person: Thomas A. Winters, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W112, Rockville, MD 20892-9750, 240-276-6386, twinters@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; NCI Clinical and Translational Exploratory/Developmental Studies (R21). Date: February 27-28, 2017. Time: 8:00 a.m. to 12:00 p.m. Agenda: To review and evaluate grant applications. Place: Ritz-Carlton Hotel, 1700 Tysons Boulevard, McLean, VA 22102. Contact Person: Hasan Siddiqui, Ph.D., Scientific Review Officer, Special Review [[Page 8620]] Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W240, Rockville, MD 20892-9750, 240-276-5122, hasan.siddiqui@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; NCI Clinical and Translational Exploratory/Developmental Studies (R03 & R21). Date: February 28, 2017. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 4W032, Rockville, MD 20850, (Telephone Conference Call). Contact Person: Thomas A. Winters, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W112, Rockville, MD 20892-9750, 240-276-6386, twinters@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis; Panel Molecularly Targeted Radiation Therapy. Date: March 1, 2017. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W538, Rockville, MD 20850, (Telephone Conference Call). Contact Person: Ivan Ding, MD, Scientific Review Officer, Program & Review Extramural Staff Training Office, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W534, Rockville, MD 20892-9750 240-276-6444, dingi@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Differential Isolation of Exosomes. Date: March 1, 2017. Time: 11:00 a.m. to 3:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 4W030, Rockville, MD 20850, (Telephone Conference Call). Contact Person: Jeffrey E. DeClue, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W114, Rockville, MD 20892-9750, 240-276-6371, decluej@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Radiation Therapy and Biomarker Identification. Date: March 2, 2017. Time: 12:00 p.m. to 4:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W538, Rockville, MD 20850, (Telephone Conference Call). Contact Person: Ivan Ding, MD, Scientific Review Officer, Program & Review Extramural Staff Training Office, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W534, Rockville, MD 20892-9750, 240-276-6444, dingi@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Informatics Technologies for Cancer Research. Date: March 9-10, 2017. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, Bethesda, MD 20852. Contact Person: Nadeem Khan, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W260, Rockville, MD 20892-9750, 240-276-5856, nadeem.khan@nih.gov Name of Committee: National Cancer Institute Special Emphasis Panel; Outstanding Investigator Award--I. Date: March 9-10, 2017. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Gaithersburg Marriott Washingtonian Center, 9751 Washingtonian Boulevard, Gaithersburg, MD 20878. Contact Person: Shamala K. Srinivas, Ph.D., Scientific Review Officer, Office of Referral, Review, and Program Coordination, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W530, Rockville, MD 20892-9750, 240-276- 6442, ss537t@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; NCI R03/R21 SEP-3. Date: March 9-10, 2017. Time: 8:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: Doubletree by Hilton Bethesda, 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Zhiqiang Zou, MD, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W242, Rockville, MD 20892-9750, 240-276-6372, zouzhiq@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: January 24, 2017. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017-01867 Filed 1-26-17; 8:45 am] BILLING CODE 4140-01-P
![Federal Register / Vol. 82, No. 17 / Friday, January 27, 2017 / Notices 8619
Time: 8:00 a.m. to 5:00 p.m. MSC 7892, Bethesda, MD 20892, 301–435– (Catalogue of Federal Domestic Assistance
Agenda: To review and evaluate grant 1154, dianne.hardy@nih.gov. Program Nos. 93.853, Clinical Research
applications. Name of Committee: Center for Scientific Related to Neurological Disorders; 93.854,
Place: Marriott Wardman Park Washington Review Special Emphasis Panel; Member Biological Basis Research in the
DC Hotel, 2660 Woodley Road NW., Conflict: Skeletal Biology and Disease. Neurosciences, National Institutes of Health,
Washington, DC 20008. Date: February 24, 2017. HHS).
Contact Person: Antonello Pileggi, MD, Time: 10:00 a.m. to 2:00 p.m. Dated: January 23, 2017.
Ph.D., Scientific Review Officer, Center for Agenda: To review and evaluate grant
Scientific Review, National Institute of Sylvia L. Neal,
applications.
Heath, 6701 Rockledge Drive, Room 6166, Place: National Institutes of Health, 6701 Program Analyst, Office of Federal Advisory
Bethesda, MD 20892–7892, (301) 402–6297, Rockledge Drive, Bethesda, MD 20892, Committee Policy.
pileggia@csr.nih.gov. (Virtual Meeting). [FR Doc. 2017–01812 Filed 1–26–17; 8:45 am]
Name of Committee: Center for Scientific Contact Person: Maria Nurminskaya, Ph.D., BILLING CODE 4140–01–P
Review Special Emphasis Panel; Member Scientific Review Officer, Center for
Conflict: Healthcare Delivery and Scientific Review, National Institutes of
Methodologies Research. Health, Bethesda, MD 20892, (301) 435–1222, DEPARTMENT OF HEALTH AND
Date: February 22, 2017. nurminskayam@csr.nih.gov.
HUMAN SERVICES
Time: 1:00 p.m. to 3:30 p.m. (Catalogue of Federal Domestic Assistance
Agenda: To review and evaluate grant Program Nos. 93.306, Comparative Medicine; National Institutes of Health
applications. 93.333, Clinical Research, 93.306, 93.333,
Agenda: Embassy Suites at the Chevy 93.337, 93.393–93.396, 93.837–93.844, National Cancer Institute; Notice of
Chase Pavilion, 4300 Military Road NW., 93.846–93.878, 93.892, 93.893, National Closed Meetings
Washington, DC 20015 (Telephone Institutes of Health, HHS)
Conference Call). Pursuant to section 10(d) of the
Dated: January 23, 2017.
Contact Person: Jacinta Bronte-Tinkew, Federal Advisory Committee Act, as
Ph.D., Scientific Review Officer, Center for Sylvia L. Neal,
amended (5 U.S.C. App.), notice is
Scientific Review, National Institutes of Program Analyst, Office of Federal Advisory
Committee Policy.
hereby given of the following meetings.
Health, 6701 Rockledge Drive, Room 3164,
MSC 7770, Bethesda, MD 20892, (301) 806–
The meetings will be closed to the
[FR Doc. 2017–01815 Filed 1–26–17; 8:45 am]
0009, brontetinkewjm@csr.nih.gov. public in accordance with the
BILLING CODE 4140–01–P
Name of Committee: Oncology 1-Basic
provisions set forth in sections
Translational Integrated Review Group; 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Tumor Cell Biology Study Section. as amended. The grant applications/
DEPARTMENT OF HEALTH AND
Date: February 23–24, 2017. contract proposals and the discussions
HUMAN SERVICES
Time: 8:00 a.m. to 5:00 p.m. could disclose confidential trade secrets
Agenda: To review and evaluate grant National Institutes of Health or commercial property such as
applications. patentable material, and personal
Place: Argonaut Hotel, 495 Jefferson Street, National Institute of Neurological information concerning individuals
San Francisco, CA 94109. associated with the grant applications/
Contact Person: Charles Morrow, MD,
Disorders and Stroke; Notice of Closed
Ph.D., Scientific Review Officer, Center for Meeting contract proposals, the disclosure of
Scientific Review, National Institutes of which would constitute a clearly
Pursuant to section 10(d) of the unwarranted invasion of personal
Health, 6701 Rockledge Drive, Room 6202, Federal Advisory Committee Act, as
MSC 7804, Bethesda, MD 20892, 301–408– privacy.
9850, morrowcs@csr.nih.gov.
amended (5 U.S.C. App.), notice is
hereby given of the following meeting. Name of Committee: National Cancer
Name of Committee: Oncology 1-Basic Institute Special Emphasis Panel; Revision
The meeting will be closed to the
Translational Integrated Review Group; Applications for Biological Comparisons in
Tumor Microenvironment Study Section. public in accordance with the Patient-Derived Models of Cancer (U01).
Date: February 23–24, 2017. provisions set forth in sections Date: February 24, 2017.
Time: 8:00 a.m. to 5:00 p.m. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant as amended. The grant applications and Agenda: To review and evaluate grant
applications. the discussions could disclose applications.
Place: Ritz-Carlton Hotel, 1700 Tysons confidential trade secrets or commercial Place: National Cancer Institute Shady
Boulevard, McLean, VA 22102. property such as patentable material, Grove, 9609 Medical Center Drive, Room
Angela Y Ng, Ph.D., Scientific Review and personal information concerning 7W032, Rockville, MD 20850, (Telephone
Officer, Center for Scientific Review, Conference Call).
individuals associated with the grant
National Institutes of Health, 6701 Rockledge Contact Person: Thomas A. Winters, Ph.D.,
Drive, Room 6200, MSC 7804, Bethesda, MD applications, the disclosure of which Scientific Review Officer, Special Review
20892, 301–435–1715, ngan@mail.nih.gov. would constitute a clearly unwarranted Branch, Division of Extramural Activities,
Name of Committee: Endocrinology, invasion of personal privacy. National Cancer Institute, 9609 Medical
Metabolism, Nutrition and Reproductive Name of Committee: Neurological Sciences Center Drive, Room 7W112, Rockville, MD
Sciences Integrated Review Group; Training Initial Review Group; NST–1 20892–9750, 240–276–6386, twinters@
Integrative and Clinical Endocrinology and Subcommittee. mail.nih.gov.
Reproduction Study Section. Date: February 27–28, 2017. Name of Committee: National Cancer
Date: February 24, 2017. Time: 8:00 a.m. to 6:00 p.m. Institute Special Emphasis Panel; NCI
Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant Clinical and Translational Exploratory/
Agenda: To review and evaluate grant applications. Developmental Studies (R21).
jstallworth on DSK7TPTVN1PROD with NOTICES
applications. Place: Catamaran Resort, 3999 Mission Date: February 27–28, 2017.
Place: The Dana on Mission Bay, 1710 Boulevard, San Diego, CA 92109. Time: 8:00 a.m. to 12:00 p.m.
West Mission Bay Drive, San Diego, CA Contact Person: William Benzing, Ph.D., Agenda: To review and evaluate grant
92109. Scientific Review Office, Scientific Review applications.
Contact Person: Dianne Hardy, Ph.D., Branch, NINDS/NIH/DHHS, Neuroscience Place: Ritz-Carlton Hotel, 1700 Tysons
Scientific Review Officer, Center for Center, 6001 Executive Blvd., Suite 3204, Boulevard, McLean, VA 22102.
Scientific Review, National Institutes of MSC 9529, Bethesda, MD 20892–9529, (301) Contact Person: Hasan Siddiqui, Ph.D.,
Health, 6701 Rockledge Drive, Room 6175, 496–0660, benzingw@mail.nih.gov. Scientific Review Officer, Special Review
VerDate Sep<11>2014 13:58 Jan 26, 2017 Jkt 241001 PO 00000 Frm 00021 Fmt 4703 Sfmt 4703 E:\FR\FM\27JAN1.SGM 27JAN1](https://thefederalregister.org/doc/82_FR_8636/page/1.svg)
![8620 Federal Register / Vol. 82, No. 17 / Friday, January 27, 2017 / Notices
Branch, Division of Extramural Activities, Institute, 9609 Medical Center Drive, Room DEPARTMENT OF HEALTH AND
National Cancer Institute, 9609 Medical 7W534, Rockville, MD 20892–9750, 240– HUMAN SERVICES
Center Drive, Room 7W240, Rockville, MD 276–6444, dingi@mail.nih.gov.
20892–9750, 240–276–5122, hasan.siddiqui@ National Institutes of Health
Name of Committee: National Cancer
nih.gov.
Institute Special Emphasis Panel; Informatics
Name of Committee: National Cancer Technologies for Cancer Research. National Institute of General Medical
Institute Special Emphasis Panel; NCI Sciences; Notice of Closed Meetings
Date: March 9–10, 2017.
Clinical and Translational Exploratory/
Developmental Studies (R03 & R21). Time: 8:00 a.m. to 6:00 p.m.
Date: February 28, 2017. Agenda: To review and evaluate grant Pursuant to section 10(d) of the
Time: 10:00 a.m. to 5:00 p.m. applications. Federal Advisory Committee Act, as
Agenda: To review and evaluate grant Place: Bethesda North Marriott Hotel & amended (5 U.S.C. App.), notice is
applications. Conference Center, 5701 Marinelli Road, hereby given of the following meetings.
Place: National Cancer Institute Shady Bethesda, MD 20852. The meetings will be closed to the
Grove, 9609 Medical Center Drive, Room Contact Person: Nadeem Khan, Ph.D., public in accordance with the
4W032, Rockville, MD 20850, (Telephone Scientific Review Officer, Research
Conference Call). provisions set forth in sections
Technology and Contract Review Branch,
Contact Person: Thomas A. Winters, Ph.D., 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Division of Extramural Activities, National
Scientific Review Officer, Special Review as amended. The grant applications and
Cancer Institute, 9609 Medical Center Drive,
Branch, Division of Extramural Activities, the discussions could disclose
Room 7W260, Rockville, MD 20892–9750,
National Cancer Institute, 9609 Medical
240–276–5856, nadeem.khan@nih.gov
confidential trade secrets or commercial
Center Drive, Room 7W112, Rockville, MD property such as patentable material,
20892–9750, 240–276–6386, twinters@ Name of Committee: National Cancer
and personal information concerning
mail.nih.gov. Institute Special Emphasis Panel;
individuals associated with the grant
Name of Committee: National Cancer Outstanding Investigator Award—I.
applications, the disclosure of which
Institute Special Emphasis; Panel Date: March 9–10, 2017.
Time: 8:00 a.m. to 5:00 p.m.
would constitute a clearly unwarranted
Molecularly Targeted Radiation Therapy.
Agenda: To review and evaluate grant invasion of personal privacy.
Date: March 1, 2017.
Time: 10:00 a.m. to 5:00 p.m. applications. Name of Committee: National Institute of
Agenda: To review and evaluate contract Place: Gaithersburg Marriott General Medical Sciences Special Emphasis
proposals. Washingtonian Center, 9751 Washingtonian Panel; Review of Centers of Biomedical
Place: National Cancer Institute Shady Boulevard, Gaithersburg, MD 20878. Research Excellence (COBRE) P20.
Grove, 9609 Medical Center Drive, Room Contact Person: Shamala K. Srinivas, Date: March 14, 2017.
7W538, Rockville, MD 20850, (Telephone Ph.D., Scientific Review Officer, Office of Time: 8:00 a.m. to 6:00 p.m.
Conference Call). Referral, Review, and Program Coordination, Agenda: To review and evaluate grant
Contact Person: Ivan Ding, MD, Scientific applications.
Division of Extramural Activities, National
Review Officer, Program & Review Place: Bethesda Marriott Suites, 6711
Cancer Institute, 9609 Medical Center Drive,
Extramural Staff Training Office, Division of
Room 7W530, Rockville, MD 20892–9750, Democracy Boulevard, Bethesda, MD 20817.
Extramural Activities, National Cancer
240–276–6442, ss537t@nih.gov. Contact Person: Shinako Takada, Ph.D.,
Institute, 9609 Medical Center Drive, Room
Name of Committee: National Cancer Scientific Review Officer, Office of Scientific
7W534, Rockville, MD 20892–9750 240–276–
6444, dingi@mail.nih.gov. Institute Special Emphasis Panel; NCI R03/ Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Name of Committee: National Cancer R21 SEP–3.
Center Drive, Room 3An.22, Bethesda, MD
Institute Special Emphasis Panel; Differential Date: March 9–10, 2017.
20892–6200, 301–402–9448,
Isolation of Exosomes. Time: 8:00 a.m. to 4:00 p.m.
shinako.takada@nih.gov.
Date: March 1, 2017. Agenda: To review and evaluate grant
Time: 11:00 a.m. to 3:00 p.m. applications. Name of Committee: National Institute of
Agenda: To review and evaluate contract Place: Doubletree by Hilton Bethesda, 8120 General Medical Sciences Special Emphasis
proposals. Wisconsin Avenue, Bethesda, MD 20814. Panel; Review of FI2 Applications:
Place: National Cancer Institute Shady Contact Person: Zhiqiang Zou, MD, Ph.D., Postdoctoral Research Associate (PRAT)
Grove, 9609 Medical Center Drive, Room Scientific Review Officer, Special Review Program.
4W030, Rockville, MD 20850, (Telephone Date: March 22, 2017.
Branch, Division of Extramural Activities,
Conference Call). Time: 8:00 a.m. to 5:00 p.m.
National Cancer Institute, 9609 Medical
Contact Person: Jeffrey E. DeClue, Ph.D., Agenda: To review and evaluate grant
Scientific Review Officer, Research Center Drive, Room 7W242, Rockville, MD
applications.
Technology and Contract Review Branch, 20892–9750, 240–276–6372, zouzhiq@
Place: Cambria Hotel, 1 Helen Heneghan
Division of Extramural Activities, National mail.nih.gov.
Way, Rockville, MD 20850.
Cancer Institute, 9609 Medical Center Drive, (Catalogue of Federal Domestic Assistance Contact Person: Robert Horowits, Ph.D.,
Room 7W114, Rockville, MD 20892–9750, Program Nos. 93.392, Cancer Construction; Scientific Review Officer, National Institute
240–276–6371, decluej@mail.nih.gov. 93.393, Cancer Cause and Prevention of General Medical Sciences, National
Name of Committee: National Cancer Research; 93.394, Cancer Detection and Institutes of Health, 45 Center Drive, Room
Institute Special Emphasis Panel; Radiation Diagnosis Research; 93.395, Cancer 3An.18, Bethesda, MD 20892–6200, 301–
Therapy and Biomarker Identification. Treatment Research; 93.396, Cancer Biology 594–6904, horowitr@mail.nih.gov.
Date: March 2, 2017. Research; 93.397, Cancer Centers Support;
Time: 12:00 p.m. to 4:00 p.m. (Catalogue of Federal Domestic Assistance
93.398, Cancer Research Manpower; 93.399, Program Nos. 93.375, Minority Biomedical
Agenda: To review and evaluate contract Cancer Control, National Institutes of Health,
proposals. Research Support; 93.821, Cell Biology and
jstallworth on DSK7TPTVN1PROD with NOTICES
HHS) Biophysics Research; 93.859, Pharmacology,
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room Dated: January 24, 2017. Physiology, and Biological Chemistry
7W538, Rockville, MD 20850, (Telephone Melanie J. Pantoja, Research; 93.862, Genetics and
Conference Call). Developmental Biology Research; 93.88,
Program Analyst, Office of Federal Advisory Minority Access to Research Careers; 93.96,
Contact Person: Ivan Ding, MD, Scientific
Committee Policy. Special Minority Initiatives; 93.859,
Review Officer, Program & Review
Extramural Staff Training Office, Division of [FR Doc. 2017–01867 Filed 1–26–17; 8:45 am] Biomedical Research and Research Training,
Extramural Activities, National Cancer BILLING CODE 4140–01–P National Institutes of Health, HHS)
VerDate Sep<11>2014 13:58 Jan 26, 2017 Jkt 241001 PO 00000 Frm 00022 Fmt 4703 Sfmt 4703 E:\FR\FM\27JAN1.SGM 27JAN1](https://thefederalregister.org/doc/82_FR_8636/page/2.svg)
Document Created: 2017-01-27 00:10:59
Document Modified: 2017-01-27 00:10:59
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | February 24, 2017. | |
| FR Citation | 82 FR 8619 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR